Terms ending in 2037
Every in-force patent on Helio LLC's record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,829,821 | Leukemia Methylation Markers and Uses Thereof In force · High confidence | Helio Health Inc. | In force | High confidence | |
| US 10,544,467 | Solid Tumor Methylation Markers and Uses Thereof In force · Medium confidence | Helio Health Inc. | In force | Medium confidence | |
| US 12,351,876 | Colon Cancer Methylation Markers and Uses Thereof In force · High confidence | Helio Health Inc. | In force | High confidence | |
| US 12,359,258 | Lung Cancer Methylation Markers and Uses Thereof In force · High confidence | Helio Health Inc. | In force | High confidence | |
| US 12,359,257 | Liver Cancer Methylation Markers and Uses Thereof In force · Medium confidence | Helio Health Inc. | In force | Medium confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.